Maobin Xie
Impact in
- Biomaterials top 1%
- Silk-based biomaterials and applications
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
Papers in
- Biomaterials 21
- Silk-based biomaterials and applications 13
- Electrospun Nanofibers in Biomedical Applications 11
Maobin Xie
53 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 117
- Biomaterials 713
- Molecular Medicine 193
- Pharmaceutical Science 175
- Rehabilitation 124
- Automotive Engineering 200
Countries citing papers authored by Maobin Xie
This map shows the geographic impact of Maobin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maobin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maobin Xie more than expected).
Fields of papers citing papers by Maobin Xie
This network shows the impact of papers produced by Maobin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maobin Xie. The network helps show where Maobin Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maobin Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 30 | |
| 11 | 2023 | 31 | |
| 12 | 2023 | 106 | |
| 13 | 2023 | 11 | |
| 14 | 2022 | 24 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 54 | |
| 17 | 2020 | 17 | |
| 18 | 2016 | 56 | |
| 19 | 2015 | 128 | |
| 20 | 2015 | 92 |
About Maobin Xie
Maobin Xie is a scholar working on Biomaterials, Molecular Medicine, Pharmaceutical Science, Rehabilitation and Biomedical Engineering, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Silk-based biomaterials and applications (13 papers), Electrospun Nanofibers in Biomedical Applications (11 papers), 3D Printing in Biomedical Research (9 papers), Innovative Microfluidic and Catalytic Techniques Innovation (8 papers), RNA Interference and Gene Delivery (8 papers), Additive Manufacturing and 3D Printing Technologies (7 papers), Extracellular vesicles in disease (5 papers) and Wound Healing and Treatments (4 papers). The work is most often cited by research in Biomaterials (713 citations), Molecular Medicine (193 citations), Pharmaceutical Science (175 citations), Rehabilitation (124 citations) and Automotive Engineering (200 citations). Maobin Xie has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi Li, Zheng Zhao, Gang Li, Yu Shrike Zhang, Ai‐Zheng Chen, Jiashen Li, Liming Lian, Guosheng Tang, Haoxiang Zhang and Jie Guo. Their work appears in journals such as Advanced Materials, Advanced Functional Materials, Materials Letters, International Journal of Biological Macromolecules and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.